Stock 0GM GRACENT AG
Add to a list
To use this feature you must be a member
Log inSign up

Financials graceNT AG

Equities

0GM

CH0289720754

Advanced Medical Equipment & Technology

End-of-day quote BOERSE DUESSELDORF
Other stock markets
 04:30:00 13/03/2024 am IST 		5-day change 1st Jan Change
0.062 EUR -.--% Intraday chart for graceNT AG -.--% -87.60%
17/06 GraceNT AG Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 GraceNT AG Reports Earnings Results for the Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 0.9817 0.0473 0.2409 0.2029 0.0474 0.2023
Enterprise Value (EV) 1 1.495 0.4985 0.7597 0.7464 0.6065 0.7637
P/E ratio - - - - - -
Yield - - - - - -
Capitalization / Revenue 26.7 x 0.76 x 3.41 x 13.2 x 9.33 x 4.97 x
EV / Revenue 40.6 x 8.06 x 10.7 x 48.6 x 119 x 18.8 x
EV / EBITDA -8.08 x -11.9 x -16.4 x -15.4 x 605 x -
EV / FCF -31.5 x - - -95 x -19.2 x -
FCF Yield -3.17% - - -1.05% -5.22% -
Price to Book - - - - - -
Nbr of stocks (in thousands) 436 436 436 436 436 436
Reference price 2 2.253 0.1085 0.5529 0.4656 0.1088 0.4643
Announcement Date 04/06/19 18/02/21 20/06/21 04/07/22 30/06/23 17/06/24
1CHF in Million2CHF
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.0368 0.0619 0.0707 0.0154 0.005083 0.0407
EBITDA 1 -0.1851 -0.0419 -0.0464 -0.0483 0.001003 -
EBIT 1 -0.1926 -0.0494 -0.0483 -0.0483 0.001002 0.0333
Operating Margin -522.98% -79.9% -68.27% -314.73% 19.71% 81.87%
Earnings before Tax (EBT) 1 -0.22 -0.011 -0.0472 -0.0356 0.0187 0.0317
Net income 1 -0.2203 -0.0114 -0.0473 -0.036 0.0183 0.0314
Net margin -598.23% -18.36% -66.88% -234.61% 360.75% 77.06%
EPS - - - - - -
Free Cash Flow 1 -0.0474 - - -0.007859 -0.0317 -
FCF margin -128.68% - - -51.17% -622.72% -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 04/06/19 18/02/21 20/06/21 04/07/22 30/06/23 17/06/24
1CHF in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 0.51 0.45 0.52 0.54 0.56 0.56
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -2.774 x -10.76 x -11.19 x -11.24 x 557.4 x -
Free Cash Flow 1 -0.05 - - -0.01 -0.03 -
ROE (net income / shareholders' equity) 65.2% 2.53% 9.89% 6.93% -3.47% -6.23%
ROA (Net income/ Total Assets) -47.9% -24.9% -49.1% -67.1% 1.43% 26.8%
Assets 1 0.4601 0.0456 0.0963 0.0537 1.281 0.1172
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 04/06/19 18/02/21 20/06/21 04/07/22 30/06/23 17/06/24
1CHF in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
GRACENT AG Stock graceNT AG
-87.60% 28.95T
DANAHER CORPORATION Stock Danaher Corporation
+8.00% 19TCr
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+31.86% 16TCr
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+33.21% 11TCr
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+2.28% 6.43TCr
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+21.14% 5.57TCr
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+0.11% 4.84TCr
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-6.76% 3.78TCr
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+0.78% 3.56TCr
RESMED, INC. Stock ResMed, Inc.
+11.28% 2.81TCr
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. 0GM Stock
  4. Financials graceNT AG